Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …

We currently have the knowledge and experience to prevent much of human papillomavirus
(HPV)-related disease burden globally. In many countries where prophylactic HPV …

For more than a decade human papillomavirus (HPV) vaccine have been implemented in
most high-income countries, and more recently also in several low-and middle-income …

Human Papillomavirus (HPV) has a significant impact in male's health, as cause of clinical
manifestations ranging from genital warts to several cancers of the anogenital and aero …

Background and aims Infection with high‐risk (HR) genotypes of the human papillomavirus
(HPV) is necessary for and causative of almost all cervical cancers and their precursor …

Abstract Background The Human Papillomavirus (HPV) is generally recognized to be the
direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in …

Background Human papillomavirus (HPV) vaccination is safe and effective in preventing
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …

Men are at high risk for HPV infection and can benefit from vaccination, but vaccination rates
among men remain extremely low. More research needs to be done on the predictors of …

Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …

Specific adult populations known to be at high risk for human papillomavirus (HPV)-related
disease, such as men who have sex with men, are inconsistently included in national …